Skip to main content
. 2026 Sep 2;18(17):2839. doi: 10.3390/cancers18172839
Abbreviation Definition
ADC antibody–drug conjugate
BCG bacillus Calmette–Guérin
CGP comprehensive genomic profiling
CI confidence interval
CPS combined positive score
DAB diaminobenzidine
dd-MVAC dose-dense methotrexate, vinblastine, doxorubicin and cisplatin
ECOG Eastern Cooperative Oncology Group
EV enfortumab vedotin
FDR false discovery rate
FFPE formalin-fixed paraffin-embedded
HR hazard ratio
ICI immune checkpoint inhibitor
IHC immunohistochemistry
IQR interquartile range
ITE impossible to evaluate
la/mUC locally advanced or metastatic urothelial carcinoma
MIBC muscle-invasive bladder cancer
MSI microsatellite instability
NAC neoadjuvant chemotherapy
OS overall survival
PBC platinum-based chemotherapy
pCR pathologic complete response
RFS recurrence-free survival
RT radiotherapy
TC tumour cell (score)
TIL tumour-infiltrating lymphocyte
TMB tumour mutational burden
TSO-500 TruSight Oncology 500
TURBT transurethral resection of bladder tumour
UC urothelial carcinoma
UTUC upper-tract urothelial carcinoma
VAF variant allele frequency
VUS variant of uncertain significance
WES whole-exome sequencing